SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jbershad who wrote (1019)1/8/1998 7:42:00 AM
From: Arthur Radley   of 2173
 
OFF TOPIC:
For those of you interested in another approach to the diabetes market, take a look at Polymedica(PM). PM is a diabetic testing company that is growing by about 10,000 new clients a month as the result of their national TV campaign. When new Medicare rules start in July their potential customer base will double as Medicare will pay for non-insulin dependent patients that need to test their condition. I have started a thread for PM (The Stock for 1998).

Good luck with your interest in AMLN. With the growing numbers that suffer from this condition we desperately need new ways to treat this problem. In my case, it is my dog that has to have two insulin shots each day.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News